Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials

Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials

Tyrosine Kinase Inhibitors (TKIs) is revolutionizing the management of pediatric Chronic Myeloid Leukemia (CML), offering alternatives to Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT). We conducted a comprehensive review of 16 Randomized Controlled Trials (RCTs) encompassing 887 pediatr...

Full description

Bibliographic Details
Main Authors: Fateen Ata, Maria Benkhadra, Rola Ghasoub, Liam J. Fernyhough, Nabil E. Omar, Abdulqadir J. Nashwan, Mahmood B. Aldapt, Kamran Mushtaq, Nancy A. Kassem, Mohamed A. Yassin
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Oncology
Subjects:
Tyrosine Kinase Inhibitors
TKI
pediatric chronic myeloid leukemia
CML
Imatinib
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1285346/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1285346/full

Similar Items